erythromycin

erythromycin is a lipid of Polyketides (PK) class. Erythromycin is associated with abnormalities such as Systemic Inflammatory Response Syndrome, Pneumonia, Infection, Pneumococcal Infections and Exanthema. The involved functions are known as Pharmacodynamics, Sterility, Agent, Drug Kinetics and Adjudication. Erythromycin often locates in Blood, peritoneal, Extracellular, Ribosomes and apicoplast. The associated genes with erythromycin are P4HTM gene, SLC33A1 gene, FAM3B gene, Operon and Homologous Gene. The related lipids are Hydroxytestosterones, Steroids, Propionate, Mycolic Acids and campesterol. The related experimental models are Mouse Model and Knock-out.

Cross Reference

Introduction

To understand associated biological information of erythromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with erythromycin?

erythromycin is suspected in Pneumonia, Infection, Gonorrhea, Cystic Fibrosis, Respiratory Tract Infections, Influenza and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with erythromycin

MeSH term MeSH ID Detail
Diabetes Mellitus, Experimental D003921 85 associated lipids
Body Weight D001835 333 associated lipids
Edema D004487 152 associated lipids
Esophageal Neoplasms D004938 20 associated lipids
Bone Resorption D001862 7 associated lipids
Arthritis D001168 41 associated lipids
Surgical Wound Infection D013530 7 associated lipids
Abscess D000038 13 associated lipids
Hypotension D007022 41 associated lipids
Acute Kidney Injury D058186 34 associated lipids
Per page 10 20 50 100 | Total 442

PubChem Associated disorders and diseases

What pathways are associated with erythromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with erythromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with erythromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with erythromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with erythromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with erythromycin?

Mouse Model

Mouse Model are used in the study 'In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.' (Falzari K et al., 2005) and Mouse Model are used in the study 'Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.' (Cynamon MH et al., 2000).

Knock-out

Knock-out are used in the study 'Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.' (McLaughlin LA et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with erythromycin

Download all related citations
Per page 10 20 50 100 | Total 13660
Authors Title Published Journal PubMed Link
Manzo L et al. [Effects of phenobarbital on the distribution of erythromycin and erythromycin aspartate in the rat]. 1976 Jan-Jun G Ital Chemioter pmid:1029694
Baggot JD and Gingerich DA Pharmacokinetic interpretation of erythromycin and tylosin activity in serum after intravenous administration of a single dose to cows. 1976 Res. Vet. Sci. pmid:1030820
Di Nucci A et al. [Metabolism of erythromycin and erythromycin aspartate in the microsomal fraction of the rat liver]. 1976 Boll. Soc. Ital. Biol. Sper. pmid:1030960
Fisher AA The safety of topical erythromycin. 1976 Contact Derm. pmid:1032121
van Ketel WG Immediate- and delayed-type allergy to erythromycin. 1976 Contact Derm. pmid:1032135
York MK et al. Characterization of antimicrobial resistance in Streptococcus pyogenes isolates from the San Francisco Bay area of northern California. 1999 J. Clin. Microbiol. pmid:10325315
Cazzola M et al. Comparative study of dirithromycin and azithromycin in the treatment of acute bacterial exacerbations of chronic bronchitis. 1999 J Chemother pmid:10326742
Bojarska-Dahlig H et al. L-aspartate of erythromycin A cyclic 11,12-carbonate, a new semisynthetic erythromycin derivative. 1976 J. Antibiot. pmid:1033178
Wu SW et al. The Staphylococcus aureus transposon Tn551: complete nucleotide sequence and transcriptional analysis of the expression of the erythromycin resistance gene. 1999 Microb. Drug Resist. pmid:10332716
Jones KL et al. Hyperglycemia attenuates the gastrokinetic effect of erythromycin and affects the perception of postprandial hunger in normal subjects. 1999 Diabetes Care pmid:10333955
Dornbusch K et al. Postantibiotic effect and postantibiotic sub-mic effect of dirithromycin and erythromycin against respiratory tract pathogenic bacteria. 1999 APMIS pmid:10335955
Mertens PR et al. Long-term extracorporeal bilirubin elimination: A case report on cascade resin plasmaperfusion. 1998 Blood Purif. pmid:10343081
Levert H et al. Time and concentration dependent influence of dirithromycin on neutrophils oxidative burst. 1999 J. Antibiot. pmid:10344566
Parsons IC et al. Structural elucidation of a novel erythromycin, 13-cyclopentyl-13-desethyl-erythromycin B, from a recombinant Saccharopolyspora erythraea strain, NRRL 2338 pIG/1. 1999 J. Antibiot. pmid:10344576
Mikami Y et al. Production of erythromycin E by pathogenic Nocardia brasiliensis. 1999 J. Antibiot. pmid:10344579
Dujovne CA Experimental investigations on the different hepatotoxic potential of erythromycin derivatives. 1976 Med Chir Dig pmid:1034861
Champney WS and Tober CL Molecular investigation of the postantibiotic effects of clarithromycin and erythromycin on Staphylococcus aureus cells. 1999 Antimicrob. Agents Chemother. pmid:10348746
Roberts MC et al. Erythromycin-resistant Neisseria gonorrhoeae and oral commensal Neisseria spp. carry known rRNA methylase genes. 1999 Antimicrob. Agents Chemother. pmid:10348754
Greiver M Practice tips. Incorporating a rapid group A streptococcus assay with the sore throat score. 1999 Can Fam Physician pmid:10349060
Simon MW Treatment of acute sinusitis in childhood with ceftibuten. 1999 Clin Pediatr (Phila) pmid:10349523
Wasilewski MM et al. Five-day dirithromycin therapy is as effective as seven-day erythromycin therapy for acute exacerbations of chronic bronchitis. 1999 J. Antimicrob. Chemother. pmid:10350384
Rosato A et al. Inducible or constitutive expression of resistance in clinical isolates of streptococci and enterococci cross-resistant to erythromycin and lincomycin. 1999 J. Antimicrob. Chemother. pmid:10350387
Fearfield LA and Staughton RC Severe vulval apocrine acne successfully treated with prednisolone and isotretinoin. 1999 Clin. Exp. Dermatol. pmid:10354177
Erickson PR and Herzberg MC Emergence of antibiotic resistant Streptococcus sanguis in dental plaque of children after frequent antibiotic therapy. 1999 May-Jun Pediatr Dent pmid:10355009
Leal AL and Castañeda E [Susceptibility to antimicrobial agents in isolates from invasive Streptococcus pneumoniae in Colombia]. 1999 Rev. Panam. Salud Publica pmid:10355313
Kalima P et al. Epidemiology of Streptococcus pneumoniae infections at the Edinburgh City Hospital: 1980-95. 1999 Epidemiol. Infect. pmid:10355789
Janovska D et al. Administration of antibiotics in combination. Determination of antibacterial effectivity of blood serum and urine after simultaneous administration of macrolides and tetracyclines. 1976 J Hyg Epidemiol Microbiol Immunol pmid:1035924
Irokawa T et al. Cholinomimetic action of macrolide antibiotics on airway gland electrolyte secretion. 1999 Am. J. Physiol. pmid:10362719
Viñado B et al. [Resistance to erythromycin in strains of Streptococcus pyogenes isolated in the province of Barcelona]. 1999 Med Clin (Barc) pmid:10363246
Tamayo M et al. Dissemination of a chloramphenicol- and tetracycline-resistant but penicillin-susceptible invasive clone of serotype 5 Streptococcus pneumoniae in Colombia. 1999 J. Clin. Microbiol. pmid:10364609
Schulte W et al. [Diffuse panbronchiolitis. A rare differential diagnosis of chronic obstructive lung disease]. 1999 Dtsch. Med. Wochenschr. pmid:10365176
Petrakis IE et al. Hyperglycaemia attenuates erythromycin-induced acceleration of solid-phase gastric emptying in idiopathic and diabetic gastroparesis. 1999 Scand. J. Gastroenterol. pmid:10365900
Cilostazol for intermittent claudication. 1999 Med Lett Drugs Ther pmid:10368703
Gregory ST and Dahlberg AE Erythromycin resistance mutations in ribosomal proteins L22 and L4 perturb the higher order structure of 23 S ribosomal RNA. 1999 J. Mol. Biol. pmid:10369764
Arum ES and Jacobs NF Nongonococcal urethritis. 1976 Cutis pmid:1037101
Hume EB et al. Clarithromycin for experimental Staphylococcus aureus keratitis. 1999 Curr. Eye Res. pmid:10372997
Gao W et al. [Analysis of 9 cases of pulmonary tuberculosis complicated with legionnaires disease]. 1997 Zhonghua Jie He He Hu Xi Za Zhi pmid:10374448
Taege AJ Listeriosis: recognizing it, treating it, preventing it. 1999 Cleve Clin J Med pmid:10375847
Alvarez-Elcoro S and Enzler MJ The macrolides: erythromycin, clarithromycin, and azithromycin. 1999 Mayo Clin. Proc. pmid:10377939
Griga T et al. [Effect of stomach motility on measuring stomach permeability with saccharose in vivo]. 1999 Z Gastroenterol pmid:10378362
Hägg S et al. Absence of interaction between erythromycin and a single dose of clozapine. 1999 Eur. J. Clin. Pharmacol. pmid:10379638
Huber R et al. Increase of cellular hypoxic tolerance by erythromycin and other antibiotics. 1999 Neuroreport pmid:10380977
Feighner SD et al. Receptor for motilin identified in the human gastrointestinal system. 1999 Science pmid:10381885
Ruckdeschel G and Dalhoff A The in-vitro activity of moxifloxacin against Legionella species and the effects of medium on susceptibility test results. 1999 J. Antimicrob. Chemother. pmid:10382872
Nishijima T et al. Distribution of mefE and ermB genes in macrolide-resistant strains of Streptococcus pneumoniae and their variable susceptibility to various antibiotics. 1999 J. Antimicrob. Chemother. pmid:10382884
Bébéar CM et al. In-vitro activity of grepafloxacin, a new fluoroquinolone, against mycoplasmas. 1999 J. Antimicrob. Chemother. pmid:10382895
McConnell SA et al. Lack of effect of dirithromycin on theophylline pharmacokinetics in healthy volunteers. 1999 J. Antimicrob. Chemother. pmid:10382900
Tzelepi E et al. Erythromycin resistance amongst group A beta-haemolytic streptococci isolated in a paediatric hospital in Athens, Greece. 1999 J. Antimicrob. Chemother. pmid:10382903
Valisena S et al. Molecular typing of erythromycin-resistant streptococcus pyogenes strains with the M phenotype isolated in Italy. 1999 Eur. J. Clin. Microbiol. Infect. Dis. pmid:10385014
Francis GS Cardiac complications in the intensive care unit. 1999 Clin. Chest Med. pmid:10386256
Cook M and Lynch WH A sensitive nested reverse transcriptase PCR assay to detect viable cells of the fish pathogen Renibacterium salmoninarum in Atlantic salmon (Salmo salar L.). 1999 Appl. Environ. Microbiol. pmid:10388701
Tanaka T et al. Effect of EM574 on postprandial pancreaticobiliary secretion, gastric motor activity, and emptying in conscious dogs. 1999 Dig. Dis. Sci. pmid:10389679
Mazzei T et al. Pharmacokinetics of dirithromycin in patients with mild or moderate cirrhosis. 1999 Antimicrob. Agents Chemother. pmid:10390202
Kawanami R et al. [Successful treatment of allergic bronchopulmonary aspergillosis with erythromycin and fluconazole]. 1999 Nihon Kokyuki Gakkai Zasshi pmid:10390974
Watanabe M et al. Role of CYP3A in haloperidol N-dealkylation and pharmacokinetics in rats. 1999 Fundam Clin Pharmacol pmid:10392310
Vesce F et al. Effect of different classes of antibiotics on amniotic prostaglandin E release. 1999 Prostaglandins Other Lipid Mediat. pmid:10402215
Bent S et al. Antibiotics in acute bronchitis: a meta-analysis. 1999 Am. J. Med. pmid:10403354
Ullmann U et al. Comparative in-vitro activity of levofloxacin, other fluoroquinolones, doxycycline and erythromycin against Ureaplasma urealyticum and Mycoplasma hominis. 1999 J. Antimicrob. Chemother. pmid:10404335
Lacey RW and Lewis EL Further evolution of a strain of Staphylococcus aureus in vivo: evidence for significant inactivation of flucloxacillin by penicillinase. 1975 J. Med. Microbiol. pmid:1040676
Classen DC et al. Clinical and financial impact of intravenous erythromycin therapy in hospitalized patients. 1999 Ann Pharmacother pmid:10410176
Oguri T et al. [Multiple drug resistance of Enterobacter-Serratia group isolated from clinical materials (author's transl)]. 1975 Jpn J Antibiot pmid:1041281
Messini M et al. Bacteremia after dental treatment in mentally handicapped people. 1999 J. Clin. Periodontol. pmid:10412852
Drici MD et al. Comparison of tegaserod (HTF 919) and its main human metabolite with cisapride and erythromycin on cardiac repolarization in the isolated rabbit heart. 1999 J. Cardiovasc. Pharmacol. pmid:10413072
Wagenvoort JH et al. How useful is the Chlamydia micro-immunofluorescence (MIF) test for the gynaecologist? 1999 Eur. J. Obstet. Gynecol. Reprod. Biol. pmid:10413220
Lin CF and Chung TC Cloning of erythromycin-resistance determinants and replication origins from indigenous plasmids of Lactobacillus reuteri for potential use in construction of cloning vectors. 1999 Plasmid pmid:10413663
Driessen JH A computer study of bacterial resistance patterns to antibiotics. 1975 Chemotherapy pmid:1041490
Finegold SM Antimicrobial therapy of anaerobic infections. 1975 Postgrad Med pmid:1041514
Matsumoto H et al. Sensitivity of fresh isolates of Haemophilus to current antibiotics. 1975 Jpn J Antibiot pmid:1041598
Lee DO and Lee CD Serotonin syndrome in a child associated with erythromycin and sertraline. 1999 Pharmacotherapy pmid:10417041
Albini E et al. In vitro antibacterial activity of thiamphenicol glycinate acetylcysteinate against respiratory pathogens. 1999 Arzneimittelforschung pmid:10417871
Kearney JA et al. In vitro activities of the oxazolidinone compounds linezolid (PNU-100766) and eperzolid (PNU-100592) against middle ear isolates of Streptococcus pneumoniae. 1999 Int. J. Antimicrob. Agents pmid:10418759
de Sousa G et al. A multi-laboratory evaluation of cryopreserved monkey hepatocyte functions for use in pharmaco-toxicology. 1999 Chem. Biol. Interact. pmid:10418972
Latorre G et al. [Chlamydia pneumoniae pneumonia]. 1998 Jan-Mar Rev Med Univ Navarra pmid:10420952
Cvetkovic M et al. OATP and P-glycoprotein transporters mediate the cellular uptake and excretion of fexofenadine. 1999 Drug Metab. Dispos. pmid:10421612
Okada J et al. [Changes of antimicrobial susceptibility of anaerobic bacteria from clinical specimens (author's transl)]. 1975 Jpn J Antibiot pmid:1042183
Bachmann K et al. A study of the interaction between dirithromycin and astemizole in healthy adults. 1997 Feb-Mar Am J Ther pmid:10423595
Callréus T et al. Changes in gastrointestinal motility influence the absorption of desmopressin. 1999 Eur. J. Clin. Pharmacol. pmid:10424324
Johnson MM et al. Effect of carbon dioxide on testing of susceptibilities of respiratory tract pathogens to macrolide and azalide antimicrobial agents. 1999 Antimicrob. Agents Chemother. pmid:10428903
Giovanetti E et al. Phenotypes and genotypes of erythromycin-resistant Streptococcus pyogenes strains in Italy and heterogeneity of inducibly resistant strains. 1999 Antimicrob. Agents Chemother. pmid:10428916
Credito KL et al. Activity of telithromycin (HMR 3647) against anaerobic bacteria compared to those of eight other agents by time-kill methodology. 1999 Antimicrob. Agents Chemother. pmid:10428930
Krecic-Shepard ME et al. In vivo comparison of putative probes of CYP3A4/5 activity: erythromycin, dextromethorphan, and verapamil. 1999 Clin. Pharmacol. Ther. pmid:10430108
Barone A et al. Microbiotica associated with refractory periodontis. Prevalence and antibiotic susceptibility. 1999 Minerva Stomatol pmid:10434536
Kumar A and Will EJ Necrotizing fasciitis and Legionnaires' disease after combined renal and pancreatic transplantation: a penalty of overseas travel. 1999 Nephrol. Dial. Transplant. pmid:10435897
Drug interactions. 1999 Med Lett Drugs Ther pmid:10436770
Sakai C et al. Nocardia asteroides pneumonia, subcutaneous abscess and meningitis in a patient with advanced malignant lymphoma: successful treatment based on in vitro antimicrobial susceptibility. 1999 Intern. Med. pmid:10440509
Kearney GC et al. Structural elucidation studies of erythromycins by electrospray tandem mass spectrometry II. 1999 Rapid Commun. Mass Spectrom. pmid:10440983
Blackwell BA et al. Oxidative deamination of hydrolyzed fumonisin B(1) (AP(1)) by cultures of Exophiala spinifera. 1999 Nat. Toxins pmid:10441035
Albini E et al. Activity of aerosol thiamphenicol glycinate acetylcysteinate in a mouse model of S. pyogenes pneumonia. 1999 Arzneimittelforschung pmid:10442213
Limia A et al. Five-year analysis of antimicrobial susceptibility of the Streptococcus milleri group. 1999 Eur. J. Clin. Microbiol. Infect. Dis. pmid:10442424
Schiano P et al. [Gastroparesis of central origin: usefulness of erythromycin]. 1999 Can J Anaesth pmid:10442972
Moss AJ et al. A review of the cardiac systemic side-effects of antihistamines: ebastine. 1999 Clin. Exp. Allergy pmid:10444238
Jones KL et al. The effect of erythromycin on gastric emptying is modified by physiological changes in the blood glucose concentration. 1999 Am. J. Gastroenterol. pmid:10445530
Vorland LH et al. Interference of the antimicrobial peptide lactoferricin B with the action of various antibiotics against Escherichia coli and Staphylococcus aureus. 1999 Scand. J. Infect. Dis. pmid:10447328
Cohen J et al. Mediterranean spotted fever in pregnancy. 1999 Scand. J. Infect. Dis. pmid:10447334
Wang H et al. Demethylation capacity of human fetal adrenal mitochondrial cytochrome P-450 in vitro. 1999 Zhongguo Yao Li Xue Bao pmid:10452125
Tamaoki J et al. Macrolide antibiotics protect against immune complex-induced lung injury in rats: role of nitric oxide from alveolar macrophages. 1999 J. Immunol. pmid:10453038
Morales WJ et al. Change in antibiotic resistance of group B streptococcus: impact on intrapartum management. 1999 Am. J. Obstet. Gynecol. pmid:10454674
Grunt J and Krcméry V Multiple drug-resistance in staphylococci, an analysis of all-nation computer-processed data. 1976 Zentralbl Bakteriol Orig A pmid:1045837
Watanakunakorn C Clindamycin therapy of Staphylococcus aureus endocarditis. Clinical relapse and development of resistance to clindamycin, lincomycin and erythromycin. 1976 Am. J. Med. pmid:1045861
Boyanova L et al. Characteristics and trends in macrolide resistance among Helicobacter pylori strains isolated in Bulgaria over four years. 1999 Diagn. Microbiol. Infect. Dis. pmid:10459482